Control method and control device for filtration membrane system, and filtration membrane system

By controlling the zeta potential of aggregates through flocculant and pH adjuster injection rates, the filtration membrane system prevents fouling, ensuring stable and efficient water filtration by minimizing aggregate adhesion to the membrane surfaces.

WO2024236892A1PCT designated stage expired Publication Date: 2024-11-21MEIDENSHA CORP
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2024/009269
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-16
Filing Date
2024-03-11
Publication Date
2024-11-21

AI Technical Summary

Technical Problem

Filtration membranes in water purification systems experience fouling due to aggregates adhering to their surfaces and pores, leading to reduced water permeation performance over time, which is not effectively addressed by existing technologies.

Method used

A method and device for controlling the filtration membrane system by adjusting the injection rates of flocculants and pH adjusters to maintain the zeta potential of aggregates within a target range, preventing their adherence to the membrane, using a control device that monitors and adjusts the pH value of flocculation-treated water to ensure optimal zeta potential for the membrane material.

Benefits of technology

This approach significantly reduces fouling and maintains stable membrane filtration performance by minimizing aggregate adhesion, thereby extending membrane lifespan and ensuring consistent water filtration quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2024009269_21112024_PF_FP_ABST
    Figure JP2024009269_21112024_PF_FP_ABST
Patent Text Reader

Abstract

This control method is for a filtration membrane system which comprises: a coagulant injection unit for injecting a coagulant into raw water; and a filtration membrane for obtaining filtered water by performing a filtration process on coagulation-treated water which is raw water containing an aggregate formed due to injection of the coagulant. The control method includes, as pretreatment prior to the filtration process with the filtration membrane, a control step for controlling the rate of injection of at least one of the coagulant and a pH adjustment agent so that the zeta potential of the aggregate falls within a target range corresponding to a material of the filtration membrane.
Need to check novelty before this filing date? Find Prior Art

Description

Filtration membrane system control method and control device, filtration membrane system

[0001] The present invention relates to a control method and control device for a filtration membrane system, and a filtration membrane system.

[0002] For example, a known membrane filtration technique for water purification processes is a coagulation / membrane filtration method in which coagulation treatment is performed prior to membrane filtration (see, for example, Patent Document 1). In the coagulation / membrane filtration method, a coagulant is injected into raw water, the raw water and the coagulant are mixed, and turbid matter, colloids, dissolved substances, etc. in the raw water react with the coagulant to form coagulates, and the water containing the coagulates is then subjected to membrane filtration to obtain filtered water.

[0003] JP 2014-168729 A

[0004] In the coagulation / membrane filtration method, over time, the coagulates that flow into the membrane filtration process adhere to the surface and pores of the filtration membrane, and the deposited coagulates clog the filtration membrane, significantly reducing its water permeability (fouling). From the perspective of suppressing fouling and achieving stable membrane filtration, it is preferable to operate the filtration membrane system in a state where coagulates are less likely to adhere to the filtration membrane.

[0005] The present invention has been made in consideration of the above circumstances, and provides a method for controlling a filtration membrane system that enables membrane filtration in a state in which aggregates are less likely to adhere to the filtration membrane, and can suppress fouling.

[0006] One aspect of the present invention is a control method for a filtration membrane system including a flocculant injection unit that injects a flocculant into raw water and a filtration membrane that filters the flocculated raw water containing flocculants formed by the injection of the flocculant to obtain filtrate. The control method includes a control step of controlling the injection rate of at least one of the flocculant and the pH adjuster as a pretreatment for the filtration by the filtration membrane so that the zeta potential of the flocculants falls within a target range appropriate for the material of the filtration membrane.

[0007] The control method may further include a preparation step of acquiring a correspondence relationship between the pH value of the coagulation-treated water and the zeta potential of the coagulate. In addition, the control step may monitor the pH value of the coagulation-treated water and control the injection rate of at least one of the coagulant and the pH adjuster based on the correspondence relationship so that the monitored pH value of the coagulation-treated water falls within a pH value range corresponding to a target range.

[0008] The filtration membrane may be an alumina-based ceramic membrane. Furthermore, in the control step, the injection rate of at least one of the flocculant and the pH adjuster may be controlled so that the zeta potential of the flocculant is −7 mV or higher. Furthermore, in the control step, the injection rate of at least one of the flocculant and the pH adjuster may be controlled so that the zeta potential of the flocculant falls within the negative region of the target range.

[0009] In the above control process, a pH adjuster may be injected into the raw water at a predetermined ratio, and the injection rate of the coagulant may be controlled so that the zeta potential of the coagulant falls within a target range depending on the material of the filtration membrane.

[0010] In the above control process, a coagulant is injected into the raw water at a predetermined ratio, and the injection rate of the pH adjuster may be controlled so that the zeta potential of the coagulant falls within a target range depending on the material of the filtration membrane.

[0011] The filtration membrane system according to the above control method may further include a settling tank for performing solid-liquid separation of the flocculated matter upstream of the filtration membrane. The filtration membrane may also filter the flocculated water after solid-liquid separation.

[0012] Another aspect is a control device for a filtration membrane system including a flocculant injection unit that injects a flocculant into raw water and a filtration membrane that filters the flocculated raw water containing flocculants formed by the injection of the flocculant to obtain filtrate. The control device has a control unit that adjusts the injection rate of at least one of the flocculant and the pH adjuster before the filtration process by the filtration membrane so that the zeta potential of the flocculants falls within a target range depending on the material of the filtration membrane.

[0013] The control device may further include a memory unit that stores data on a correspondence relationship between the pH value of the coagulation-treated water and the zeta potential of the coagulate. The control unit may acquire the pH value of the coagulation-treated water and, based on the correspondence relationship, control the injection rate of at least one of the coagulant and the pH adjuster so that the pH value of the coagulation-treated water falls within a pH value range corresponding to a target range.

[0014] Yet another aspect of the filtration membrane system includes a flocculant injection section that injects a flocculant into raw water, a filtration membrane that filters the flocculated raw water containing flocculants formed by the injection of the flocculant to obtain filtered water, and the above-mentioned control device.

[0015] According to one aspect, a method for controlling a filtration membrane system can be provided that enables membrane filtration in a state where aggregates are less likely to adhere to the filtration membrane, thereby suppressing fouling.

[0016] 1 is a diagram showing an example of the configuration of a filtration membrane system of a first embodiment. FIG. 2 is a diagram showing an example of the configuration of a filtration membrane system of a second embodiment. FIG. 3 is a diagram showing an example of the configuration of a filtration membrane system of a third embodiment. FIG. 4 is a diagram showing an example of the configuration of a filtration membrane system of a fourth embodiment. (a) is a flowchart showing an example of a control method for the filtration membrane system of the first embodiment, (b) is a flowchart showing an example of a control method for the filtration membrane system of the third embodiment, and (c) is a flowchart showing an example of a control method for the filtration membrane system of the fourth embodiment. FIG. 5 is a graph showing the flocculant injection rate, the zeta potential of the flocculants, and the pH of the flocculation-treated water in the flocculation-treated water of the first example. FIG. 6 is a graph showing the zeta potential of the flocculants and the rate of increase in the transmembrane pressure of the filtration membrane when the pH of the flocculation-treated water into which a flocculant has been injected is changed in the first example. FIG. 7 is a graph showing the flocculant injection rate, the zeta potential of the flocculants, and the pH of the flocculation-treated water in the flocculation-treated water of the second example. FIG. 8 is a graph showing the flocculant injection rate, the zeta potential of the flocculants, and the pH of the flocculation-treated water in the flocculation-treated water of the third example.

[0017] Hereinafter, embodiments of the present invention will be described with reference to the drawings. In the embodiments, in order to make the description easier to understand, structures and elements other than the main parts of the present invention will be described in a simplified or omitted manner. In addition, the same elements will be given the same reference numerals in the drawings. Note that the shapes, dimensions, etc. of each element shown in the drawings are shown schematically and do not represent the actual shapes, dimensions, etc.

[0018] (First embodiment) In the first embodiment, in a filtration membrane system that combines coagulation treatment and membrane filtration treatment, the coagulation treatment prior to the membrane filtration treatment controls the coagulant injection rate so that the zeta potential of the coagulants generated by coagulant injection falls within a target range appropriate for the material of the filtration membrane. In the first embodiment, the zeta potential of the residual coagulants contained in the raw water (coagulation-treated water) into which coagulant has been injected and that flows into the membrane filtration process is set to an appropriate range appropriate for the membrane material, thereby reducing the adhesion of the residual coagulants to the surface and pores of the filtration membrane. This suppresses fouling due to clogging of the filtration membrane, enabling stable membrane filtration.

[0019] 1 is a diagram showing a configuration example of a filtration membrane system according to a first embodiment. The filtration membrane system 1 according to the first embodiment includes a coagulant injection unit 2, a retention tank 4, a settling tank 5, a membrane filtration tank 6, and a control device 10.

[0020] Raw water containing turbidity, colloids, and dissolved substances is supplied to the filtration membrane system 1 via a raw water pipe 7. The downstream side of the raw water pipe 7 is connected to a retention tank 4. For example, the raw water may be raw tap water such as river water, groundwater, or lake water, or may be wastewater such as domestic sewage, rainwater, or industrial wastewater.

[0021] The flocculant injection section 2 is connected to the raw water pipe 7 upstream of the retention tank 4, and injects a flocculant into the raw water flowing through the raw water pipe 7. Downstream of the flocculant injection section 2, the raw water and the flocculant are mixed, causing turbidity, colloids, and dissolved substances contained in the raw water to react with the flocculant. This produces flocs in the raw water.

[0022] Examples of the flocculant include ferric chloride, polyferric sulfate, polysilica iron, aluminum sulfate, polyaluminum chloride, high-basicity polyaluminum chloride, and mixtures thereof. The flocculants may contain a flocculation aid such as a polymer. In this embodiment, the case where ferric chloride is used as the flocculant will be described.

[0023] The retention tank 4 is a water tank for temporarily retaining the coagulation-treated water containing coagulants. The retention tank 4 is connected to the downstream settling tank 5 via a pipe 7a. The retention tank 4 is also provided with a pH meter 8 for measuring the pH of the coagulation-treated water. The location of the pH meter 8 is not limited to the retention tank 4; for example, the pH meter 8 may be provided in the raw water pipe 7 downstream of the coagulant injection section 2.

[0024] The settling tank 5 allows the coagulated treated water flowing in from the retention tank 4 to stand and separates it into solid components and a supernatant liquid. This supernatant liquid is supplied to the downstream membrane filtration tank 6 via pipe 7b. The solid components concentrated in the settling tank 5 are transferred to an external sludge treatment facility (not shown).

[0025] The membrane filtration tank 6 has a filtration membrane 9 that filters the coagulation-treated water that has undergone primary treatment in the settling tank 5. In the membrane filtration tank 6, the coagulation remaining in the coagulation-treated water is filtered by the filtration membrane 9, and filtrate from which the coagulation has been separated and removed is produced.

[0026] Examples of the filtration membrane 9 that can be used include ceramic membranes primarily composed of silica, alumina, silicon carbide, cordierite, and mixtures thereof, organic membranes such as PVDF (polyvinylidene fluoride) and PTFE (polytetrafluoroethylene), and hybrid membranes of ceramic and organic membranes. In this embodiment, a ceramic membrane primarily composed of alumina is used as the filtration membrane 9.

[0027] The ceramic and organic membrane materials used for the filtration membrane 9 each have a positive or negative charge in water. For example, a ceramic membrane whose main component is alumina has a positively charged membrane surface in near-neutral water or water with a pH of 5 to 8. In addition, the membrane surface of an organic membrane such as PVDF is usually negatively charged in water.

[0028] For example, when the aggregates contained in the coagulated water are strongly negatively charged in a ceramic membrane mainly composed of alumina, the aggregates are likely to be adsorbed onto the positively charged surface of the membrane, which is likely to cause clogging of the filtration membrane 9. When clogging of the filtration membrane 9 by the aggregates becomes severe, the transmembrane pressure difference increases, causing membrane filtration failure.

[0029] When the membrane material is positively charged in water, if the flocculants contained in the coagulation-treated water are positively charged, the adsorption of the flocculants to the membrane surface decreases, and the progress of clogging of the filtration membrane 9 slows. Also, in the above case, even if the flocculants contained in the coagulation-treated water are negatively charged, if the charge amount decreases, the adsorption of the flocculants to the positively charged membrane surface decreases. The strength of the charge amount of the flocculants is indicated by the zeta potential. The larger the absolute value of the zeta potential of the flocculants, the greater the charge amount of the flocculants, and conversely, the smaller the absolute value of the zeta potential of the flocculants, the less the charge amount of the flocculants.

[0030] In the case of an organic membrane such as PVDF, the membrane surface is usually negatively charged in water as described above. If the membrane material is negatively charged in water, the aggregates contained in the coagulation treatment water can be negatively charged or the charge amount of the aggregates can be reduced (i.e., the absolute value of the zeta potential of the aggregates can be reduced), making it difficult for the aggregates to adsorb to the membrane surface.

[0031] Although not particularly limited, in the case of a ceramic membrane containing alumina as the main component, it is preferable to adjust the zeta potential of the aggregates to the positive side of −10 mV (more preferably −7 mV or more) from the viewpoint of making it difficult for the aggregates to be adsorbed on the surface of the membrane.

[0032] Furthermore, in the case of a ceramic membrane containing alumina as its main component, it is preferable to adjust the zeta potential of the aggregates to fall within the negative region of the target range, from the viewpoint of making it difficult for the aggregates to be adsorbed on the membrane surface while suppressing the amount of flocculant injection. As an example, in the case of a ceramic membrane containing alumina as its main component, it is more preferable to adjust the zeta potential of the aggregates to fall within the region of −7 mV or more and in the vicinity of −7 mV (for example, the range of −7 mV or more and −3 mV or less).

[0033] The control device 10 controls the flocculant injection rate of the flocculant injector 2 so that the zeta potential of the flocculants generated by the flocculation treatment falls within a target range according to the membrane material. The control device 10 is, for example, a computer having a CPU (Central Processing Unit) 10a, a memory 10b, and a storage device 10c, and is connected to the pH meter 8 and the flocculant injector 2. The CPU 10a and the memory 10b are examples of a control unit, and the memory 10b and the storage device 10c are examples of a storage unit.

[0034] The CPU 10a executes programs stored in the storage device 10c and controls each element connected to the control device 10. The memory 10b functions as the main memory and work area of ​​the CPU 10a. The storage device 10c is configured, for example, by a hard disk or solid state drive, and stores programs and various data required to execute the programs. Note that the control device 10 may be configured by a hardware circuit.

[0035] Here, the correspondence relationship between the zeta potential of flocculants in raw water and the pH value varies depending on the type of raw water and the state of the raw water at any given time. Therefore, the storage device 10c or memory 10b of this embodiment pre-stores data indicating the correspondence relationship between the zeta potential of flocculants and the pH value when the flocculant injection rate is changed for the raw water to be treated. Since the above correspondence relationship is known for the raw water to be treated, the pH value when the zeta potential of the flocculants falls within a target range corresponding to the membrane material (for example, the zeta potential of the flocculants is more positive than -10 mV) can be set as the adjustment target pH value. The above correspondence data is set before the filtration membrane system 1 starts operating, but may be updated as appropriate after operation has started.

[0036] The above-mentioned correspondence data is generated by an operator by preparing multiple samples of coagulation-treated water with different coagulant injection rates and measuring the zeta potential of the flocculants and the pH value of the coagulation-treated water for each sample. To measure the zeta potential of each sample, for example, electrophoresis may be used to measure the zeta potential of flocculant particles of a predetermined size or smaller contained in the sample, and the zeta potential of the flocculants may be determined by averaging these values. The pH value of each sample can also be determined using a common pH measurement method.

[0037] The control device 10 of this embodiment performs the following operation, for example: First, the control device 10 acquires and monitors the current pH value of the coagulation-treated water from the pH meter 8. The current pH value correlates with the zeta potential of the coagulates in the coagulation-treated water.

[0038] The control device 10 then instructs the flocculant injector 2 to change the flocculant injection rate so that the pH value measured by the pH meter 8 falls within the range of the target pH value that indicates an appropriate range for the zeta potential of the flocculant. As a result, the flocculant injection rate of the flocculant injector 2 is feedback-controlled in accordance with the pH value of the raw water after the flocculant is injected.

[0039] For example, if the absolute value of the zeta potential of the flocculant estimated from the current pH value is large, the control device 10 increases the flocculant injection rate so as to lower the pH value and reduce the absolute value of the zeta potential of the flocculant. On the other hand, if the pH value is outside the target range due to an excessive amount of flocculant injection, the control device 10 reduces the flocculant injection rate under conditions where the pH value falls within the target range. The amount of change in the flocculant injection rate may be automatically set by the control device 10 based on a program, or may be set based on operator input.

[0040] 5A is a flow chart showing an example of a control method for the filtration membrane system 1 of the first embodiment. In the preparation step (S1), raw water is collected to prepare multiple samples of coagulation-treated water at different coagulant injection rates, and the zeta potential of the coagulants and the pH value of the coagulation-treated water are measured for each sample. This generates data on the correspondence between the zeta potential of the coagulants and the pH value of the coagulants when the coagulant injection rate is changed for the raw water to be treated. The generated data on the correspondence is stored in the storage device 10c or memory 10b of the control device 10 and read by the CPU 10a.

[0041] In the flocculant injection step (S2), the flocculant injection unit 2 injects a flocculant into the raw water in the raw water piping 7 at a set flocculant injection rate. This causes flocculants to be produced in the flocculated water. After the flocculant injection, the flocculated water flows through the retention tank 4 and the settling tank 5 into the membrane filtration tank 6, where it is filtered by the filtration membrane 9.

[0042] Meanwhile, in the pH measurement step (S3), the pH meter 8 measures the pH value of the flocculation-treated water after flocculant injection. In the injection rate adjustment step (S4), the control device 10 adjusts the flocculant injection rate based on the above-mentioned correspondence data acquired in the preparation step (S1) and the pH value measured in the pH measurement step (S3) so that the zeta potential of the flocculant falls within the range of the adjustment target pH value, which indicates an appropriate range. Then, the process returns to S2 and the above process is repeated. Note that the flocculant injection step (S2), pH measurement step (S3), and injection rate adjustment step (S4) are examples of control steps.

[0043] As described above, in the flocculant injection section 2 of the first embodiment, a flocculant is injected into the raw water so as to reduce the absolute value of the zeta potential of the flocculants, and the charge amount of the flocculants is reduced downstream of the flocculant injection section 2. As a result, even if flocculants remaining in the flocculation-treated water flow into the membrane filtration tank 6, clogging of the filtration membrane 9 is unlikely to occur because the flocculants have low adsorption to the surface of the filtration membrane 9.

[0044] In this embodiment, the pH value of the coagulation-treated water after coagulant injection is measured and monitored using a pH meter 8, and the coagulant injection rate is adjusted so that the zeta potential of the coagulant falls within a target pH range that indicates an appropriate range. Although it is difficult to continuously monitor the zeta potential of the coagulant, in this embodiment, the coagulant injection rate is controlled using the pH value, thereby making it possible to appropriately control the zeta potential of the coagulant, which is difficult to monitor continuously.

[0045] Second Embodiment Fig. 2 is a diagram showing a configuration example of a filtration membrane system 1A according to a second embodiment. In the following description of the embodiment, elements common to the first embodiment are designated by the same reference numerals, and redundant description will be omitted as appropriate.

[0046] The filtration membrane system 1A of the second embodiment is a modified example of the first embodiment, and corresponds to a configuration in which the retention tank 4 and the settling tank 5 are omitted from the filtration membrane system 1 of the first embodiment. In the second embodiment, the downstream side of the raw water piping 7 is connected to a membrane filtration tank 6, and the coagulant injection unit 2 is connected to the raw water piping 7 upstream of the membrane filtration tank 6. In addition, a pH meter 8 that measures the pH of the coagulation-treated water is provided in the membrane filtration tank 6. Note that the location of the pH meter 8 is not limited to the membrane filtration tank 6, and the pH meter 8 may be provided, for example, in the raw water piping 7 downstream of the coagulant injection unit 2.

[0047] As in the first embodiment, the control device 10 of the second embodiment instructs the flocculant injector 2 to change the flocculant injection rate so that the pH value measured by the pH meter 8 falls within the range of the target pH value that indicates an appropriate range for the zeta potential of the floc. The configuration of the second embodiment can also achieve the same effects as those of the first embodiment.

[0048] 3 is a diagram showing a configuration example of a filtration membrane system 1B according to a third embodiment. The filtration membrane system 1B according to the third embodiment is a configuration example in which a pH adjuster and a coagulant are both injected into raw water.

[0049] The filtration membrane system 1B of the third embodiment includes a pH adjuster injection unit 3, a flocculant injection unit 2, a retention tank 4, a settling tank 5, a membrane filtration tank 6, and a control device 10. The downstream side of the raw water piping 7 of the third embodiment is connected to the retention tank 4. The raw water piping 7 is also connected to the pH adjuster injection unit 3 and the flocculant injection unit 2. In the third embodiment, the configurations of the flocculant injection unit 2, the retention tank 4, the settling tank 5, and the membrane filtration tank 6 are the same as those of the first embodiment.

[0050] The pH adjuster injection unit 3 is disposed upstream of the coagulant injection unit 2, and injects a pH adjuster at a predetermined ratio into the raw water flowing through the raw water pipe 7. Examples of pH adjusters include acids such as hydrochloric acid and sulfuric acid, and alkalis such as caustic soda and lime. However, the types of acids and alkalis used as pH adjusters are not limited to those mentioned above.

[0051] For example, if the membrane material is positively charged in water, adjusting the pH of the raw water to be more acidic with a pH adjuster can adjust the zeta potential of the aggregates produced in the aggregation process to be more positive. Therefore, adjusting the pH of the raw water can also reduce the adsorption of aggregates to the membrane surface.

[0052] The configuration and operation of the control device 10 of the third embodiment are the same as those of the first embodiment. However, in the third embodiment, data showing the correspondence relationship between the zeta potential of the flocculants and the pH value when the flocculant injection rate is changed for raw water to be treated is generated by preparing multiple samples of flocculation-treated water into which a pH adjuster is injected at a predetermined ratio and into which different amounts of flocculant are injected, and measuring the zeta potential of the flocculants and the pH value of the flocculation-treated water for each sample.

[0053] 5B is a flow chart showing an example of a control method for the filtration membrane system 1B of the third embodiment. In the preparation step (S11), raw water is collected, and multiple samples of coagulation-treated water are prepared by injecting a pH adjuster at a predetermined ratio and varying the coagulant injection rate. The zeta potential of the coagulants and the pH value of the coagulation-treated water are measured for each sample. This generates data on the correspondence between the zeta potential of the coagulants and the pH value when the coagulant injection rate is varied for the raw water to be treated. The generated data on the correspondence is stored in the storage device 10c or memory 10b of the control device 10 and read by the CPU 10a.

[0054] In the pH adjuster injection step (S12), the pH adjuster injection unit 3 injects a pH adjuster into the raw water in the raw water piping 7 at a predetermined ratio. In the flocculant injection step (S13), the flocculant injection unit 2 injects a flocculant into the raw water in the raw water piping 7 at a set flocculant injection rate. This causes the flocculant to react with turbidity, colloids, and dissolved substances contained in the raw water, producing flocculants in the flocculated water. Furthermore, the flocculated water after flocculation injection flows into the membrane filtration tank 6 via the retention tank 4 and the settling tank 5, and is filtered by the filtration membrane 9.

[0055] Meanwhile, in the pH measurement step (S14), the pH meter 8 measures the pH value of the flocculation-treated water after flocculant injection. In the injection rate adjustment step (S15), the control device 10 adjusts the flocculant injection rate based on the above-mentioned correspondence data acquired in the preparation step (S11) and the pH value measured in the pH measurement step (S14) so ​​that the zeta potential of the flocculant falls within the range of the adjustment target pH value, which indicates an appropriate range. Then, the process returns to S13 and the above process is repeated. Note that the pH adjuster injection step (S12), flocculant injection step (S13), pH measurement step (S14), and injection rate adjustment step (S15) are examples of control steps.

[0056] As described above, in the third embodiment, a flocculant and a pH adjuster are used in combination, and the flocculant injection unit 2 adjusts the flocculant injection rate so that the zeta potential of the flocculant falls within the target pH range, which indicates an appropriate range. The third embodiment can also achieve the same effects as the first embodiment. Furthermore, the third embodiment has the advantage that the amount of flocculant used can be reduced compared to when the flocculant is used alone, as in the first embodiment.

[0057] In the third embodiment, an example has been described in which the pH adjuster is injected at a predetermined ratio and then the coagulant injection unit 2 injects the coagulant, but it is also possible for the pH injection unit 3 to inject the pH adjuster at a predetermined ratio after the coagulant injection unit 2 injects the coagulant.

[0058] (Fourth embodiment) Figure 4 is a diagram showing a configuration example of a filtration membrane system of the fourth embodiment. Similar to the third embodiment, the filtration membrane system 1C of the fourth embodiment is a configuration example in which a pH adjuster and a coagulant are injected into raw water in combination. The fourth embodiment differs from the third embodiment in that the injection rate of the coagulant is fixed at a predetermined ratio and the injection rate of the pH adjuster is adjusted.

[0059] The filtration membrane system 1C of the fourth embodiment includes a flocculant injection unit 2, a pH adjuster injection unit 3, a retention tank 4, a settling tank 5, a membrane filtration tank 6, and a control device 10. The downstream side of the raw water piping 7 of the fourth embodiment is connected to the retention tank 4. The raw water piping 7 is also connected to the pH adjuster injection unit 3 and the flocculant injection unit 2. In the fourth embodiment, the configurations of the retention tank 4, the settling tank 5, and the membrane filtration tank 6 are the same as those of the first embodiment.

[0060] The flocculant injection unit 2 injects a flocculant at a predetermined ratio into raw water flowing through the raw water pipe 7. The pH adjuster injection unit 3 is disposed downstream of the flocculant injection unit 2 and injects a pH adjuster into raw water (flocculation-treated water) flowing through the raw water pipe 7. The control device 10 of the fourth embodiment controls the injection rate of the pH adjuster in the pH adjuster injection unit 3 so that the zeta potential of the flocculants produced by the flocculation treatment falls within a target range.

[0061] 5(c) is a flow chart showing an example of a control method for the filtration membrane system 1C of the fourth embodiment. In the preparation step (S21), raw water is collected, and multiple samples of coagulation-treated water are prepared by injecting a coagulant at a predetermined ratio and varying the injection rate of a pH adjuster. The zeta potential of the coagulation and the pH value of the coagulation-treated water are measured for each sample. This generates data on the correspondence between the zeta potential of the coagulation and the pH value when the pH adjuster is varied for the raw water to be treated. The generated data on the correspondence is stored in the storage device 10c or memory 10b of the control device 10 and read by the CPU 10a.

[0062] In the flocculant injection step (S22), the flocculant injection unit 2 injects a flocculant into the raw water in the raw water piping 7 at a predetermined ratio. This causes flocculants to be produced in the flocculated water. In the pH adjuster injection step (S23), the pH adjuster injection unit 3 injects a pH adjuster into the flocculated water in the raw water piping 7 at a set pH adjuster injection rate. The flocculated water after the injection of the flocculant and pH adjuster flows into the membrane filtration tank 6 via the retention tank 4 and the settling tank 5, and is filtered by the filtration membrane 9.

[0063] Meanwhile, in the pH measurement step (S24), the pH meter 8 measures the pH value of the flocculation-treated water after the injection of the flocculant and pH adjuster. In the injection rate adjustment step (S25), the control device 10 adjusts the pH adjuster injection rate based on the above-mentioned correspondence data acquired in the preparation step (S21) and the pH value measured in the pH measurement step (S24) so ​​that the zeta potential of the flocculant falls within the range of the adjustment target pH value, which indicates an appropriate range. Thereafter, the process returns to S23 and the above process is repeated. Note that the flocculant injection step (S22), pH adjuster injection step (S23), pH measurement step (S24), and injection rate adjustment step (S25) are examples of control steps.

[0064] As described above, in the fourth embodiment, a coagulant and a pH adjuster are used in combination, and the pH value of the coagulation-treated water is adjusted so as to reduce the absolute value of the zeta potential of the coagulate by controlling the injection amount of the pH adjuster. In the fourth embodiment, the same effects as in the third embodiment can be obtained.

[0065] In the fourth embodiment, an example was described in which the pH adjuster injection unit 3 injects a pH adjuster after injecting a coagulant at a predetermined ratio, but it is also possible for the pH adjuster injection unit 3 to inject a pH adjuster and then for the coagulant injection unit 2 to inject a coagulant at a predetermined ratio.

[0066] First Example The following describes an example of the present invention. In the first example, river water was used as raw water and ferric chloride was used as a coagulant. The coagulant injection rate was varied to measure the zeta potential of the coagulants contained in the supernatant water of the coagulated water and the pH of the coagulated water. A zeta potential measuring device (Malvern, Zetasizer, Nano ZS) using electrophoresis was used to measure the zeta potential.

[0067] Fig. 6 is a graph showing the flocculant injection rate, the zeta potential of the flocculants, and the pH of the flocculation-treated water in Example 1. The horizontal axis of Fig. 6 represents the flocculant injection rate, the vertical axis on the left side of Fig. 6 represents the zeta potential, and the vertical axis on the right side of Fig. 6 represents the pH of the flocculation-treated water. The solid line graph in Fig. 6 represents the change in zeta potential with respect to the flocculant injection rate, and the dashed line graph in Fig. 6 represents the change in pH of the flocculation-treated water with respect to the flocculant injection rate.

[0068] Normally, flocculants contained in river water are negatively charged. Even in the case of Example 1 shown in Figure 6, when the injection rate of flocculant (ferric chloride) was zero, the zeta potential of the flocculants was -22 mV, and the flocculants were negatively charged. In Example 1, as the injection rate of ferric chloride increased, the zeta potential of the flocculants rose to near zero, and eventually the zeta potential turned positive. In other words, Figure 6 shows that as the injection rate of ferric chloride increased, the absolute value of the zeta potential decreased, and the amount of charge on the surface of the flocculants decreased.

[0069] Furthermore, the pH of the river water used as raw water in Example 1 was 8.0, but the pH decreased with increasing ferric chloride injection rate, reaching pH 5.0 at an injection rate of 60 mg / L. In Example 1, when the ferric chloride injection rate was 24 mg / L, the pH was 6.5, and the zeta potential of the flocculants under these conditions was -7 mg / L (Example 1 in Figure 7, described below). When the ferric chloride injection rate was 28 mg / L, the pH was 6.2, and the zeta potential of the flocculants under these conditions was -5 mV (Example 2 in Figure 7, described below). Furthermore, when the ferric chloride injection rate was 34 mg / L, the pH was 6.0, and the zeta potential of the flocculants under these conditions was -3 mV (Example 3 in Figure 7, described below). The graph in Figure 6 shows that by monitoring the pH, the flocculant injection rate can be controlled so that the zeta potential of the flocculants reaches a predetermined value.

[0070] In addition, in Example 1, the rate of increase in transmembrane pressure during membrane filtration was measured to evaluate the stability of membrane filtration in the membrane filtration process. A membrane module incorporating multiple ceramic flat membranes was used in the membrane filtration process of Example 1. The membrane module was designed to collect filtered water from each ceramic flat membrane in a water collection pipe. The membrane module was immersed in a membrane separation tank, and a filtration pump was connected to the water collection pipe through piping, and membrane-filtered water was obtained by suction with the filtration pump. The transmembrane pressure was calculated from the value of a pressure gauge installed in the filtration piping, and the rate of increase in transmembrane pressure was obtained from its change over time.

[0071] Figure 7 shows the zeta potential of the flocculants and the rate of increase in transmembrane pressure across the filtration membrane when the pH of the flocculating treatment water into which a flocculant was injected was changed in Example 1. In Figure 7, when the pH setting value was set to 6.8 to 7.4 (Comparative Examples 1 to 3 in Figure 7), the zeta potential of the flocculants was in the range of -15 to -10 mV. In these Comparative Examples 1 to 3, the rate of increase in transmembrane pressure was 20 to 30 kPa / d, indicating that membrane clogging progressed at a rapid rate.

[0072] In contrast, in Figure 7, when the pH setting value was set to 6.0 to 6.5 (Examples 1 to 3 in Figure 7), the injection rate of ferric chloride was 24 to 34 mg / L, the zeta potential of the aggregates was in the range of -3 to -7 mV, and the rate of increase in transmembrane pressure was 1.2 to 2.0 kPa / d. In Examples 1 to 3, the transmembrane pressure rate was reduced to one-tenth or less of that of Comparative Examples 1 to 3.

[0073] As described above, according to the first embodiment, by injecting a coagulant and controlling the pH of the coagulation-treated water so that the zeta potential of the coagulants falls within a predetermined range, it is possible to significantly suppress membrane blockage and achieve stable membrane filtration.

[0074] (Second Example) As with the third embodiment, the second example uses both pH adjustment using a pH adjuster and coagulant injection. In the second example, river water was used as raw water, sulfuric acid was used as the pH adjuster, and ferric chloride was used as the coagulant. The coagulant injection rate was varied, and the zeta potential of the coagulants contained in the supernatant water of the coagulation-treated water and the pH of the coagulation-treated water were measured. The original river water had a pH of 8.0, but in the second example, sulfuric acid was pre-injected to adjust the pH of the raw water to 7.0 before coagulant injection.

[0075] 8 is a graph showing the coagulant injection rate, the zeta potential of the coagulation product, and the pH of the coagulation-treated water in Example 2. The way to read FIG. 8 is the same as FIG.

[0076] When sulfuric acid was pre-injected as in Example 2, it was found that the zeta potential of the flocculants could be adjusted to -7 to -3 mV at an injection rate of ferric chloride of 14 to 23 mg / L. The rate of increase in the transmembrane pressure difference within the above range was 1.2 to 2.0 kPa / d, and stable membrane filtration was achieved, similar to Examples 1 to 3 in Figure 7 above.

[0077] Comparing Example 2 with Example 1, in which no pH adjustment was performed in addition to coagulant injection, the ferric chloride injection rate was 24 to 34 mg / L in Example 1, but the ferric chloride injection rate was 14 to 23 mg / L in Example 2. In other words, by combining coagulant injection and pH adjustment with a pH adjuster, as in Example 2, it is clear that stable membrane filtration can be achieved while keeping the coagulant injection rate low.

[0078] (Example 3) In Example 3, river water was used as the raw water, and aluminum sulfate was used instead of ferric chloride as the coagulant. The coagulant injection rate was changed, and the zeta potential of the coagulants contained in the supernatant water of the coagulation-treated water and the pH of the coagulation-treated water were measured.

[0079] 9 is a graph showing the coagulant injection rate, the zeta potential of the coagulation product, and the pH of the coagulation-treated water in Example 3. The way to read FIG. 9 is the same as FIG.

[0080] In the first example, in which ferric chloride was used as the coagulant, the pH was 6.0 to 6.5 when the coagulant injection rate was 24 to 34 mg / L, and the zeta potential of the coagulant under these conditions was -3 to -7 mV. On the other hand, as shown in Figure 9, in the third example, in which aluminum sulfate was used as the coagulant, the pH was 6.0 to 6.5 when the coagulant injection rate was 80 to 120 mg / L, and the zeta potential of the coagulant under these conditions was -3 to -7 mV. The rate of increase in the transmembrane pressure within the above range was 1.2 to 2.0 kPa / d, and stable membrane filtration was achieved, similar to Examples 1 to 3 in Figure 7 above.

[0081] According to the third embodiment, it is clear that even when a flocculant different from that used in the first embodiment is used, the same effect as that of the first embodiment can be obtained.

[0082] The present invention is not limited to the above-described embodiment, and various improvements and design changes may be made without departing from the spirit of the present invention.

[0083] In the above embodiment, the control device 10 changes the injection rate of either the flocculant or the pH adjuster. However, the control device 10 may perform control to change both the injection rate of the flocculant and the injection rate of the pH adjuster.

[0084] Furthermore, the embodiments disclosed herein should be considered to be illustrative and not restrictive in all respects. The scope of the present invention is defined by the claims, not by the above description, and is intended to include all modifications within the meaning and scope of the claims.

[0085] 1, 1A, 1B, 1C... Filtration membrane system, 2... flocculant injection section, 3... pH adjuster injection section, 4... retention tank, 5... sedimentation tank, 6... membrane filtration tank, 7... raw water piping, 7a, 7b... piping, 8... pH meter, 9... filtration membrane, 10... control device, 10a... CPU, 10b... memory, 10c... storage device

Claims

1. A control method for a filtration membrane system comprising a flocculant injection section which injects a flocculant into raw water, and a filtration membrane which filters the flocculated treated water of the raw water containing flocculants formed by the injection of the flocculant to obtain filtered water, the control method including a control step of controlling the injection rate of at least one of the flocculant and pH adjuster so that the zeta potential of the flocculants falls within a target range according to the material of the filtration membrane, as a pretreatment for the filtration process by the filtration membrane.

2. A control method for a filtration membrane system as described in claim 1, further comprising a preparation step of acquiring a correspondence between the pH value of the coagulation treated water and the zeta potential of the coagulate, and in the control step, the pH value of the coagulation treated water is monitored, and based on the correspondence, the injection rate of at least one of the coagulant and the pH adjuster is controlled so that the monitored pH value of the coagulation treated water falls within a pH value range corresponding to the target range.

3. A method for controlling a filtration membrane system according to claim 1 or 2, wherein the filtration membrane is an alumina-based ceramic membrane, and in the control step, an injection rate of at least one of the flocculant and the pH adjuster is controlled so that the zeta potential of the flocculant is -7 mV or higher.

4. A control method for a filtration membrane system as described in claim 3, wherein in the control process, the injection rate of at least one of the flocculant and the pH adjuster is controlled so that the zeta potential of the flocculant falls within the negative region of the target range.

5. A control method for a filtration membrane system as described in claim 1 or claim 2, wherein in the control process, the pH adjuster is injected into the raw water at a predetermined ratio, and the injection rate of the coagulant is controlled so that the zeta potential of the coagulant falls within a target range corresponding to the material of the filtration membrane.

6. A control method for a filtration membrane system as described in claim 1 or claim 2, wherein in the control process, the coagulant is injected into the raw water at a predetermined ratio, and the injection rate of the pH adjuster is controlled so that the zeta potential of the coagulant falls within a target range corresponding to the material of the filtration membrane.

7. A method for controlling a filtration membrane system as described in claim 1 or claim 2, wherein the filtration membrane system further comprises a settling tank upstream of the filtration membrane for performing solid-liquid separation of the flocculated matter, and the filtration membrane filters the flocculated treated water after solid-liquid separation.

8. A control device for a filtration membrane system comprising a flocculant injection section for injecting a flocculant into raw water, and a filtration membrane for filtering flocculated treated water of the raw water containing flocculants formed by the injection of the flocculant to obtain filtered water, the control device having a control unit for adjusting the injection rate of at least one of the flocculant and pH adjuster so that the zeta potential of the flocculants falls within a target range corresponding to the material of the filtration membrane prior to the filtration process by the filtration membrane.

9. The control device described in claim 8, further comprising a memory unit for storing data on the correspondence between the pH value of the coagulation treatment water and the zeta potential of the coagulate, wherein the control unit acquires the pH value of the coagulation treatment water, and controls the injection rate of at least one of the coagulant and the pH adjuster based on the correspondence so that the pH value of the coagulation treatment water falls within a pH value range corresponding to the target range.

10. A filtration membrane system comprising: a flocculant injection section for injecting a flocculant into raw water; a filtration membrane for filtering flocculated treated water of the raw water containing flocculants formed by the injection of the flocculant to obtain filtered water; and a control device as described in claim 8 or claim 9.

Citation Information

Patent Citations

  • Method for removing particulate matter from aqueous suspension

    JP2002136969A

  • Water treating method and its device

    JP2009248028A

  • Method for operating film module

    JP2010227836A

  • Method for evaluating membrane-clogging property of to-be-treated water, method for determining flocculation treatment condition of to-be-treated water, and apparatus for evaluating membrane-clogging property of to-be-treated water

    JP2022006582A

  • Solid-liquid separation method

    WO2013187378A1